Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:3186328.
doi: 10.1155/2017/3186328. Epub 2017 Nov 23.

HLA Association with Drug-Induced Adverse Reactions

Affiliations
Review

HLA Association with Drug-Induced Adverse Reactions

Wen-Lang Fan et al. J Immunol Res. 2017.

Abstract

Adverse drug reactions (ADRs) remain a common and major problem in healthcare. Severe cutaneous adverse drug reactions (SCARs), such as Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) with mortality rate ranges from 10% to more than 30%, can be life threatening. A number of recent studies demonstrated that ADRs possess strong genetic predisposition. ADRs induced by several drugs have been shown to have significant associations with specific alleles of human leukocyte antigen (HLA) genes. For example, hypersensitivity to abacavir, a drug used for treating of human immunodeficiency virus (HIV) infection, has been proposed to be associated with allele 57:01 of HLA-B gene (terms HLA-B57:01). The incidences of abacavir hypersensitivity are much higher in Caucasians compared to other populations due to various allele frequencies in different ethnic populations. The antithyroid drug- (ATDs- ) induced agranulocytosis are strongly associated with two alleles: HLA-B38:02 and HLA-DRB108:03. In addition, HLA-B15:02 allele was reported to be related to carbamazepine-induced SJS/TEN, and HLA-B57:01 in abacavir hypersensitivity and flucloxacillin induced drug-induced liver injury (DILI). In this review, we summarized the alleles of HLA genes which have been proposed to have association with ADRs caused by different drugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cresswell P., Ackerman A. L., Giodini A., Peaper D. R., Wearsch P. A. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunological Reviews. 2005;207(1):145–157. doi: 10.1111/j.0105-2896.2005.00316.x. - DOI - PubMed
    1. Shiina T., Hosomichi K., Inoko H., Kulski J. K. The HLA genomic loci map: expression, interaction, diversity and disease. Journal of Human Genetics. 2009;54(1):15–39. doi: 10.1038/jhg.2008.5. - DOI - PubMed
    1. Bray R. A., Hurley C. K., Kamani N. R., et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biology of Blood and Marrow Transplantation. 2008;14(9):45–53. doi: 10.1016/j.bbmt.2008.06.014. - DOI - PubMed
    1. International drug monitoring. The role of national centres. Report of a WHO meeting. World Health Organization Technical Report Series. 1972;498:1–25. - PubMed
    1. Edwards I. R., Aronson J. K. Adverse drug reactions: definitions, diagnosis, and management. The Lancet. 2000;356(9237):1255–1259. doi: 10.1016/S0140-6736(00)02799-9. - DOI - PubMed